Statement on Rand Study on Hospital Prices

Tom Nickels
Executive Vice President
American Hospital Association

September 18, 2020 

It is unfortunate that RAND continues to make broad claims about pricing based on a cherry-picked and limited data set. For example, the study again perpetuates erroneous suggestions that Medicare payments should be used as a benchmark for private insurers, in spite of Medicare reimbursing well below the cost of providing care. The authors also rely on research short-cuts. This includes a hand-picked sample of employers and insurers whose claims represent just 0.7% of inpatient admissions and 1.8% of outpatients visits over the study period, as well as measuring quality through Leapfrog data that may be old or imprecise.

These concerns are compounded by a global pandemic that represents the greatest financial threat in history for hospitals and health systems. The case for pulling resources from care providers was weak from the start. It is beyond reckless to advance this approach now.


Contact: Marie Johnson, (202) 626-2351,
                Sean Barry, (202) 626-2306,


Related Resources

The American Hospital Association urged the Centers for Medicare…
Members of the House and Senate Telehealth Caucus recently introduced the CONNECT for Health Act (S.1512/H.R. 2903), AHA-supported legislation that would…
The hospital price transparency rule took effect Jan. 1, 2021. CMS verified for the AHA that the agency has begun proactive audits of hospital websites and a…
Special Bulletin
The House of Representatives tonight voted 384-38 to pass a bill that, among other health care provisions, would eliminate the 2% across-the-board cut to all…
In a letter to Representatives Terri Sewell and Vern Buchanan the AHA expresses support of the Resetting the Impact Act (TRIA) of 2021.
Fourteen organizations, including the AHA, urge the Department of Health and Human Services to extend the Next Generation Accountable Care Organization model…